Meeting
2022 ASCO Quality Care Symposium
Evaluation of initiatives including an EHR prompt (EP) and APP involvement to increase germline genetic testing compliance in a pancreatic cancer population.
Authors
Rebecca Ronnen
Astera Cancer Care, East Brunswick, NJ
Rebecca Ronnen, Rachel Carroll, Lauren Kiley, Melissa Cruz-Tanner, Rosemary Montes, Sameer P. Desai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Application of Quality Improvement Tools
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 302)
DOI
10.1200/JCO.2022.40.28_suppl.302
Abstract #
302
Poster Bd #
C9
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.
First Author: Matthew B. Yurgelun
Poster
2019 ASCO Annual Meeting
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.
First Author: Matthew B. Yurgelun
Poster
2021 ASCO Annual Meeting
Analysis of real-world (RW) data for metastatic breast cancer (mBC) patients (pts) with somatic BRCA1/2 (sBRCA) or other homologous recombination (HR)-pathway gene mutations (muts) treated with PARP inhibitors (PARPi).
First Author: Felipe Batalini
Poster
2021 Genitourinary Cancers Symposium
Evaluation of germline genetic testing criteria in early-onset kidney cancer.
First Author: Hong Truong